John C Roche Hanover Insurance Group, Inc. (THG) insider trading activity

THG Quotes by TradingView

John C Roche is President and CEO of HANOVER INSURANCE GROUP, INC.. Currently has a direct ownership of 106,083 shares of THG, which is worth approximately $17.4 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 1,025 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 106K
6.75% 3M change
15.06% 12M change
Total Value Held $17.4 Million

John C Roche Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 06 2024
SELL
Bona fide gift
-
1,025 Reduced 0.96%
106,083 Common Stock
Nov 05 2024
SELL
Other acquisition or disposition
-
6,802 Reduced 5.97%
107,108 Common Stock
Sep 27 2024
BUY
Grant, award, or other acquisition
-
143 Added 0.13%
113,910 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
-
167 Added 0.15%
113,766 Common Stock
Mar 28 2024
BUY
Grant, award, or other acquisition
-
153 Added 0.13%
113,599 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
9,311 Added 7.58%
113,446 Common Stock
Feb 26 2024
SELL
Payment of exercise price or tax liability
$1,512,074 $134.61 p/Share
11,233 Reduced 9.74%
104,135 Common Stock
Feb 26 2024
BUY
Grant, award, or other acquisition
-
15,442 Added 11.8%
115,367 Common Stock
Feb 16 2024
SELL
Payment of exercise price or tax liability
$1,909,521 $135.88 p/Share
14,053 Reduced 12.33%
99,925 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
$1,218,076 $54.61 p/Share
22,305 Added 16.37%
113,978 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
-
162 Added 0.18%
91,673 Common Stock
Dec 01 2023
SELL
Payment of exercise price or tax liability
$85,811 $125.09 p/Share
686 Reduced 0.74%
91,511 Common Stock
Sep 29 2023
BUY
Grant, award, or other acquisition
-
173 Added 0.19%
92,197 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
-
168 Added 0.18%
92,024 Common Stock
Mar 31 2023
BUY
Grant, award, or other acquisition
-
147 Added 0.16%
91,855 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$1,397,171 $139.48 p/Share
10,017 Reduced 9.85%
91,708 Common Stock
Feb 27 2023
BUY
Grant, award, or other acquisition
-
23,505 Added 18.77%
101,725 Common Stock
Feb 24 2023
SELL
Payment of exercise price or tax liability
$463,444 $139.34 p/Share
3,326 Reduced 4.08%
78,220 Common Stock
Feb 24 2023
BUY
Exercise of conversion of derivative security
$253,503 $40.01 p/Share
6,336 Added 7.21%
81,546 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
-
130 Added 0.17%
75,210 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
-
127 Added 0.17%
75,079 Common Stock
Jun 24 2022
BUY
Grant, award, or other acquisition
-
109 Added 0.15%
74,952 Common Stock
Apr 21 2022
SELL
Open market or private sale
$143,131 $155.24 p/Share
922 Reduced 1.22%
74,843 Common Stock
Apr 21 2022
BUY
Exercise of conversion of derivative security
$36,889 $40.01 p/Share
922 Added 1.2%
75,765 Common Stock
Mar 29 2022
SELL
Open market or private sale
$410,031 $150.47 p/Share
2,725 Reduced 3.51%
74,843 Common Stock
JCR

John C Roche

President and CEO
Worcester, MA

Track Institutional and Insider Activities on THG

Follow HANOVER INSURANCE GROUP, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THG shares.

Notify only if

Insider Trading

Get notified when an Hanover Insurance Group, Inc. insider buys or sells THG shares.

Notify only if

News

Receive news related to HANOVER INSURANCE GROUP, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on THG